Cargando…

Emodin alleviates gemcitabine resistance in pancreatic cancer by inhibiting MDR1/P-glycoprotein and MRPs expression

Gemcitabine is a gold standard chemotherapeutic agent for pancreatic cancer. However, gemcitabine has limited effectiveness due to the short-term development of chemoresistance. Emodin, a natural anthraquinone derivative isolated from the roots of rheumatic palm leaves prevents immunosuppression and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Hongchun, Liu, Feng, Yang, Shuguang, Xue, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471752/ https://www.ncbi.nlm.nih.gov/pubmed/32934734 http://dx.doi.org/10.3892/ol.2020.12030

Ejemplares similares

Emodin reverses leukemia multidrug resistance by competitive inhibition and downregulation of P-glycoprotein
por: Min, Hongping, et al.
Publicado: (2017)

Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro
por: LIU, DIAN-LEI, et al.
Publicado: (2011)

Emodin reverses resistance to gemcitabine in pancreatic cancer by suppressing stemness through regulation of the epithelial‑mesenchymal transition
por: Wei, Weitian, et al.
Publicado: (2022)

Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway
por: Tong, Hongfei, et al.
Publicado: (2020)

Plasmodium falciparum Multidrug Resistance Proteins (pfMRPs)
por: Gil, José Pedro, et al.
Publicado: (2021)

Gemcitabine-Loaded Albumin Nanoparticle Exerts An Antitumor Effect on Gemcitabine-Resistant Pancreatic Cancer Cells Induced by MDR1 and MRP1 Overexpression in Vitro
por: Kong, Lei, et al.
Publicado: (2022)

Anlotinib Reverses Multidrug Resistance (MDR) in Osteosarcoma by Inhibiting P-Glycoprotein (PGP1) Function In Vitro and In Vivo
por: Wang, Gangyang, et al.
Publicado: (2022)

Emodin Alleviates Intestinal Barrier Dysfunction by Inhibiting Apoptosis and Regulating the Immune Response in Severe Acute Pancreatitis
por: Zhou, Qi, et al.
Publicado: (2021)

Investigation of the role of multidrug resistance proteins (MRPs) in vascular homeostasis
por: Allen, Robert M H, et al.
Publicado: (2015)

Astaxanthin inhibits gemcitabine-resistant human pancreatic cancer progression through EMT inhibition and gemcitabine resensitization
por: Yan, Tao, et al.
Publicado: (2017)

Expression of MDR1/P glycoprotein in human sarcomas.
por: Vergier, B., et al.
Publicado: (1993)

Emodin Alleviates High-Glucose-Induced Pancreatic β-Cell Pyroptosis by Inhibiting NLRP3/GSDMD Signaling
por: Xing, Yiqian, et al.
Publicado: (2022)

Raltegravir does not revert efflux activity of MDR1-P-glycoprotein in human MDR cells
por: Dupuis, Maria Luisa, et al.
Publicado: (2013)

HIF-1α Inhibition Reverses Multidrug Resistance in Colon Cancer Cells via Downregulation of MDR1/P-Glycoprotein
por: Chen, Jianfang, et al.
Publicado: (2014)

Down-regulation of MRPS23 inhibits rat breast cancer proliferation and metastasis
por: Gao, Yan, et al.
Publicado: (2017)

Modifications of hemoglobin and myoglobin by Maillard reaction products (MRPs)
por: Ioannou, Aristos, et al.
Publicado: (2017)

The value of RPS15 and MRPS27 in ischemic stroke
por: Zhao, Man, et al.
Publicado: (2023)

Selective inhibition of MDR1 P-glycoprotein-mediated transport by the acridone carboxamide derivative GG918
por: Wallstab, A, et al.
Publicado: (1999)

Quantitative Structure–Activity Relationships for the Flavonoid-Mediated Inhibition of P-Glycoprotein in KB/MDR1 Cells
por: Xia, Mengmeng, et al.
Publicado: (2019)

Emodin enhances osteogenesis and inhibits adipogenesis
por: Yang, Feng, et al.
Publicado: (2014)

Association between MDR1 gene of gastrointestinal tumors, the expression of P-glycoprotein and resistance to chemotherapeutic drugs
por: Su, Jian-Li, et al.
Publicado: (2017)

Emodin Alleviates Sodium Taurocholate–Induced Pancreatic Ductal Cell Damage by Inhibiting the S100A9/VNN1 Signaling Pathway
por: Guo, Fangyue, et al.
Publicado: (2022)

4-Acetylantroquinonol B enhances cell death and inhibits autophagy by downregulating the PI3K/Akt/MDR1 pathway in gemcitabine-resistant pancreatic cancer cells
por: Chen, Ying-Yin, et al.
Publicado: (2022)

Emodin alleviates LPS-induced inflammatory response in lung injury rat by affecting the function of granulocytes
por: Mei, Hongxia, et al.
Publicado: (2020)

Catalytic Transitions in the Human MDR1 P-Glycoprotein Drug Binding Sites
por: Wise, John G.
Publicado: (2012)

Emodin alleviates myocardial ischemia/reperfusion injury by inhibiting gasdermin D-mediated pyroptosis in cardiomyocytes
por: Ye, Bozhi, et al.
Publicado: (2019)

MRPS25 mutations impair mitochondrial translation and cause encephalomyopathy
por: Bugiardini, Enrico, et al.
Publicado: (2019)

Metformin alleviates adriamycin resistance of osteosarcoma by declining YY1 to inhibit MDR1 transcriptional activity
por: Wu, Bowen, et al.
Publicado: (2023)

P300 inhibition enhances gemcitabine-induced apoptosis of pancreatic cancer
por: Ono, Hiroaki, et al.
Publicado: (2016)

Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway
por: Zhou, Yunjiang, et al.
Publicado: (2019)

Inhibitory Effects of Neochamaejasmin B on P-Glycoprotein in MDCK-hMDR1 Cells and Molecular Docking of NCB Binding in P-Glycoprotein
por: Pan, Lanying, et al.
Publicado: (2015)

TRAIL sensitize MDR cells to MDR-related drugs by down-regulation of P-glycoprotein through inhibition of DNA-PKcs/Akt/GSK-3β pathway and activation of caspases
por: Seo, Suk-Bin, et al.
Publicado: (2010)

HIV-1 integrase inhibitors are substrates for the multidrug transporter MDR1-P-glycoprotein
por: Cianfriglia, Maurizio, et al.
Publicado: (2007)

Emodin inhibits pancreatic cancer EMT and invasion by up-regulating microRNA-1271
por: Li, Nan, et al.
Publicado: (2018)

Emodin and baicalein inhibit sodium taurocholate-induced vacuole formation in pancreatic acinar cells
por: Li, Jun, et al.
Publicado: (2018)

MRPS30-DT Knockdown Inhibits Breast Cancer Progression by Targeting Jab1/Cops5
por: Wu, Balu, et al.
Publicado: (2019)

Emodin and Aloe-Emodin Suppress Breast Cancer Cell Proliferation through ERα Inhibition
por: Huang, Pao-Hsuan, et al.
Publicado: (2013)

Cell Metabolomics Reveals the Potential Mechanism of Aloe Emodin and Emodin Inhibiting Breast Cancer Metastasis
por: Cheng, Guorong, et al.
Publicado: (2022)

Genetic variants in the MRPS30 region and postmenopausal breast cancer risk
por: Huang, Ying, et al.
Publicado: (2011)

Genetic variants in the MRPS30 region and postmenopausal breast cancer risk
por: Huang, Ying, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_8eqp4mj2c28rudrt4u7tqv7jvf